Bridgefront Capital’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,965
Closed -$726K 819
2025
Q3
$726K Buy
+4,965
New +$750K 0.21% 153
2025
Q2
Sell
-3,077
Closed -$507K 897
2025
Q1
$507K Sell
3,077
-1,739
-36% -$289K 0.15% 250
2024
Q4
$785K Buy
+4,816
New +$861K 0.26% 109
2024
Q2
Sell
-4,222
Closed -$714K 689
2024
Q1
$714K Buy
+4,222
New +$791K 0.54% 30
2023
Q1
Sell
-5,756
Closed -$844K 615
2022
Q4
$844K Buy
+5,756
New +$852K 0.59% 28
2022
Q2
Sell
-1,166
Closed -$220K 456
2022
Q1
$220K Buy
+1,166
New +$231K 0.27% 191
2021
Q2
Sell
-13,604
Closed -$2.14M 953
2021
Q1
$2.14M Buy
13,604
+12,165
+845% +$1.93M 0.67% 4
2020
Q4
$238K Buy
+1,439
New +$234K 0.08% 456

Other funds holding ZTS

Bridgefront Capital's ZTS Position: Q4 2025 in Review

Bridgefront Capital sold out of Zoetis (ZTS) in Q4 2025, closing a stake of 4,965 shares — an estimated $726K sold.

Bridgefront Capital first reported a position in ZTS in Q4 2020 and held it in 8 quarters. The position peaked at $2.14M in Q1 2021. 1,679 funds tracked by Wall St. Rank hold ZTS as of Q4 2025.

  • Bridgefront Capital reported no remaining Zoetis position as of Q4 2025 after selling out during the quarter.
  • Bridgefront Capital sold 4,965 Zoetis shares in Q4 2025, an estimated $726K.
  • Bridgefront Capital first reported a position in Zoetis in Q4 2020 and held it in 8 quarters.
  • Bridgefront Capital's Zoetis position peaked at $2.14M in Q1 2021.
  • 1,679 funds tracked by Wall St. Rank held Zoetis as of Q4 2025.

Based on Bridgefront Capital's 13F filing for Q4 2025, filed 13 Feb 2026.